Overcoming tumour tissue heterogeneity and difficulties in obtaining longitudinal tumour samples has led researchers to focus on evaluating PD-L1 expression on CTCs for predictive and real-time monitoring of immune cell activation (106). Here, CD274 is linked to neoplasm.